However, in the vast majority of cases, patients with skin cutaneous melanoma (SKCM; P = 0.034, HR = 0.75) with high levels of STAT3 expression had a significantly better median survival time than those with low expression. This evidence concerns the gene STAT3 and cutaneous melanoma.